Investing.com - LumiraDx (NASDAQ: LMDX) reported fourth quarter EPS of $-0.120, $0.07 better than the analyst estimate of $-0.191. Revenue for the quarter came in at $41.12M versus the consensus estimate of $51M.
LumiraDx's stock price closed at $0.860. It is down -8.360% in the last 3 months and down -90.320% in the last 12 months.
LumiraDx saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See LumiraDx's stock price’s past reactions to earnings here.
According to InvestingPro, LumiraDx's Financial Health score is "fair performance".
Check out LumiraDx's recent earnings performance, and LumiraDx's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar